Compare NRSN & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRSN | LUCY |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 7.2M |
| IPO Year | 2021 | 2021 |
| Metric | NRSN | LUCY |
|---|---|---|
| Price | $1.44 | $0.82 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $91.75 | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 114.5K |
| Earning Date | 09-25-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,661,669.00 |
| Revenue This Year | N/A | $170.51 |
| Revenue Next Year | N/A | $205.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.65 |
| 52 Week Low | $0.25 | $0.65 |
| 52 Week High | $7.50 | $2.02 |
| Indicator | NRSN | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 31.32 | 44.17 |
| Support Level | $0.61 | $0.78 |
| Resistance Level | $7.50 | $0.89 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 24.85 | 52.01 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.